Background Vaccination against respiratory syncytial virus (RSV) during pregnancy may
protect infants from RSV disease. Efficacy and safety data on a candidate RSV prefusion F …

Background Assessment of COVID-19 vaccines safety during pregnancy is urgently needed.
Methods We conducted a systematic review and meta-analysis to evaluate the safety of …

Background Understanding the safety of vaccines is critical to inform decisions about
vaccination. Our objective was to conduct a systematic review of the safety of vaccines …

Highlights-Vaccination against pertussis in pregnancy is safe for pregnant women and
newborns.-Vaccination against pertussis during the second or early third trimester of …

Vaccination in pregnancy is the best strategy to reduce complications from influenza or
pertussis infection in infants who are too young to be protected directly from vaccination …

Objective Severe pertussis infection has been reported in infants before receiving routine
immunization series. This problem could be solved by vaccinating mothers during …

Background Pregnancy is a critical time for vaccine decision-making, but coverage remains
suboptimal for maternal influenza (45–60%) and pertussis vaccination (65–80%) in …

The objective of this study was to evaluate the safety of prenatal tetanus, diphtheria,
acellular pertussis (Tdap) vaccination. This cohort study was conducted among pregnant …

Background Respiratory syncytial virus (RSV) fusion protein stabilized in the prefusion
conformation (RSVPreF3) was under investigation as a maternal vaccine. Methods This …

Background Several countries have introduced maternal immunisation with pertussis
vaccine to provide protection against pertussis in early infancy. There is increasing interest …